Eden semaglutide review
Advertised at $99, billed at $198. Position 10 of 16 on our board.
Updated 2026-09-18
Eden advertises $99 semaglutide before its membership, while Coreage Rx starts at $79 a month equivalent on a twelve-month plan. Their headlines have different terms; the complete bill is the useful comparison.
Eden’s $39 introductory membership renews at $99 a month, taking the working figure to about $198. Coreage Rx charges no membership. The medication is the same category of compounded product in both cases.
The numbers
| Eden · semaglutide | |
|---|---|
| Advertised | $99/mo |
| Membership | $99/mo |
| Billed | $198/mo |
| Advertised-to-billed gap | +$99/mo |
| Per year | $2,376 |
| Board position | 10 of 16, cheapest first |
Membership effectively doubles the advertised $99 medication price from month two onward.
Where the gap is
$99 a month, every month, from the second statement. About $1,188 a year, which happens to be the entire annual cost of the cheapest listing on the board.
Against the board
About $2,376 a year at the recorded Eden recurring rate. Coreage Rx semaglutide is $948 on a twelve-month plan, Zealthy $1,812 and Mochi $2,136 with an insurance team included.
| Programme | Advertised | Billed | Gap | Vs board floor |
|---|---|---|---|---|
| Coreage Rx | $79 | $139 | +$60 | +$54/mo |
| SuperHealthy Rx | $85 | $85 | none | — |
| Likeness Rx | $79 | $139 | +$60 | +$54/mo |
| Ozari Health | $86 | $86 | none | +$1/mo |
| Trimi | $99 | $99 | none | +$14/mo |
| Zealthy | $151 | $151 | none | +$66/mo |
| Mochi Health | $99 | $178 | +$79 | +$93/mo |
| Hims & Hers | $79 | $188 | +$109 | +$103/mo |
How the programme works
Compounded GLP-1 marketplace that advertises low medication prices and bills a separate recurring membership.
Verified facts
- Compounded semaglutide advertised at $99/month.
- Compounded tirzepatide advertised at $199/month.
- Membership is $39 as an introductory rate, then $99/month ongoing.
- True ongoing cost for tirzepatide lands near $298/month once membership is included.
Checked 2026-09-18. This market re-prices without notice — anything older than a month is a starting point, not a quote.
For it
- Genuinely low medication-only pricing.
- Fast onboarding with flat rates across published dose ranges.
Against it
- The membership renews at $99/month after the $39 introductory period.
- Advertised prices exclude the fee that most affects the yearly total.
Read this bit. The $99 semaglutide headline becomes roughly $198/month once the membership renews at its ongoing rate.
Score
3.1 out of 5 on our rubric, which is fixed before assessment and published on how we rate.
| Criterion | Weight | Score |
|---|---|---|
| True monthly cost | 30% | 3.1 / 5 |
| Price honesty | 20% | 2.6 / 5 |
| Clinical support | 20% | 3.3 / 5 |
| Pharmacy sourcing | 15% | 3.4 / 5 |
| Cancelling | 15% | 3.1 / 5 |
Verdict
The $99 is true and incomplete. Price it at $198 and it reads as an ordinary mid-market listing rather than a bargain.
More from the desk
- Coreage Rx semaglutide review
Advertised at $79, billed at $139. Position 1 of 16 on our board.
- Likeness Rx semaglutide review
Advertised at $79, billed at $139. Position 3 of 16 on our board.
- Cheapest right now
Every programme sorted on what it bills, not what it advertises. Floor: $199/mo tirzepatide, $139/mo semaglutide.
- Six fee traps
Compare the product, supply period, recurring charge and commitment before treating a headline as the full bill.
- Where the traps are
The biggest advertised-to-billed gaps on our board, and the programmes charging most for the same category of medication.
Coreage Rx pays us a commission on sign-ups through our links. It does not affect our scores or rankings. How we rate · Disclosure